[{"type": "title", "data": "ONC Venous Thromboembolism (VTE) Prophylaxis (Module)"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Step 1:  VTE prophylaxis may not be indicated when:", "value": ""}, {"type": "note", "data": " - Expected length of stay less than 24 hours.  Reassess if length of stay is extended beyond 24 hours\n - Already receiving anticoagulation therapy", "value": ""}, {"type": "note", "data": "See ambulate order in Step 4", "value": ""}, {"type": "order", "data": "Ambulate", "value": ""}, {"type": "sentence", "data": "No anticoagulant or no mechanical prophylaxis required"}, {"type": "note", "data": "Step 2: Pharmacological prophylaxis contraindicated when:", "value": ""}, {"type": "note", "data": "Prophylactic anticoagulants contraindicated in:   \n- High risk of serious bleeding or bleeding into a critical site (e.g. intracranial, epidural, pericardial, intraocular, retroperitoneal, intra-articular)    \n- Active bleeding of clinical significance requiring intervention     \n- Uncontrolled systolic hypertension of 180 mmHg or higher  \n- Platelet count less than 50 x 10^9/L (consider Hematology consult)    \n- Known major bleeding disorder or acquired coagulopathy (such as due to acute liver failure)   \n- Lumbar puncture/epidural/spinal anesthesia expected within next 12 hours \n- Lumbar puncture/epidural/spinal anesthesia received in previous 4 hours  \n- History of heparin induced thrombocytopenia (HIT) (consider Hematology consult)  \n- History of hypersensitivity to LMWH or unfractionated heparin (consider Hematology consult)  ", "value": ""}, {"type": "note", "data": "Reassess daily to start pharmacologic prophylaxis if contraindication resolves", "value": ""}, {"type": "order", "data": "VTE Prophylaxis Contraindication", "value": ""}, {"type": "sentence", "data": "Contraindication: Active Bleeding Requiring Intervention"}, {"type": "sentence", "data": "Contraindication: Risk of Serious Bleed in Critical Site"}, {"type": "sentence", "data": "Contraindication: Uncontrolled Systolic Hypertension of 180 mmHg or Higher"}, {"type": "sentence", "data": "Contraindication: Platelet Count Less Than 50 x 10^9/L"}, {"type": "sentence", "data": "Contraindication: Known Major Bleed Disorder/Coagulopathy"}, {"type": "sentence", "data": "Contraindication: Lumbar Puncture/Epidural/Spinal Anesthesia Expected Within Next 12 Hours"}, {"type": "sentence", "data": "Contraindication: Lumbar Puncture/Epidural/Spinal Anesthesia Received in Previous 4 Hours"}, {"type": "sentence", "data": "Contraindication: Hx of heparin-induced thrombocytopenia, DO NOT give LMWH or heparin"}, {"type": "sentence", "data": "Contraindication: Receiving Therapeutic Anticoagulant"}, {"type": "note", "data": "Step 3: Provide VTE prophylaxis for patients who do not meet criteria in Step 1 or 2", "value": ""}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "5,000 unit, subcutaneous, qPM, drug form: syringe-inj"}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "2,500 unit, subcutaneous, qPM, drug form: syringe-inj"}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "5,000 unit, subcutaneous, q12h, drug form: syringe-inj"}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "2,500 unit, subcutaneous, qPM, drug form: syringe-inj"}, {"type": "order", "data": "heparin", "value": ""}, {"type": "sentence", "data": "5,000 unit, subcutaneous, q12h, drug form: inj"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Nursing to provide education for symptoms of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)"}, {"type": "note", "data": "Step 4", "value": ""}, {"type": "order", "data": "Ambulate", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}]
